On October 4, 2016, the Competition Bureau announced the release of its report on Advertising Restrictions in health care services. The Bureau analyzed advertising restrictions in some of Canada’s health care industries, and surveyed a broad cross-section of provincial regulations governing pharmaceutical, dental, and veterinarian services across Canada. It found that most regulators of these services tended to restrict advertising in some form, but that there is insufficient evidence to assess whether these restrictions are achieving their policy objectives. The report reviews economic literature that shows that reducing or removing advertising restrictions does not lead to consumers experiencing lower quality in services, and may allow consumers to benefit from lower prices. However, the Bureau found that the data necessary to conduct similar studies are not readily accessible in Canada. The report calls on governments and self-regulatory bodies to begin collecting and compiling information on marketplace outcomes in Canada’s health care markets, and to move toward greater emphasis on empirical evidence in decision-making. Such data could then be made available to researchers, which would allow evidence-based assessments to be made of the suitability of advertising restrictions.